The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Sheep and Goat Pox Vaccines-Global Market Insights and Sales Trends 2024

Sheep and Goat Pox Vaccines-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1838344

No of Pages : 102

Ask Your Query
Synopsis
A single vaccine against sheep and goat pox (capripox) has been developed to protect sheep and goats throughout the capripox enzootic area.
The global Sheep and Goat Pox Vaccines market size is expected to reach US$ 72 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Sheep and Goat Pox Vaccines in various end use industries. The expanding demands from the Sheep and Goat, are propelling Sheep and Goat Pox Vaccines market. Attenuated Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
The increasing incidence of Sheep and Goat Pox, a contagious viral disease affecting small ruminants, is driving the demand for vaccines. Factors such as the growing livestock industry, rising awareness about animal health, and government initiatives for disease control contribute to market expansion. Key players in the market are focusing on product development and strategic collaborations to gain a competitive advantage. Advancements in vaccine technology, such as the use of recombinant DNA techniques, are expected to fuel market growth. However, challenges such as regulatory hurdles and limited availability of vaccines in certain regions may impede market progress. Overall, the Sheep and Goat Pox vaccines market is projected to experience substantial growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sheep and Goat Pox Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sheep and Goat Pox Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sheep and Goat Pox Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sheep and Goat Pox Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sheep and Goat Pox Vaccines covered in this report include Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd. and JOVAC, etc.
The global Sheep and Goat Pox Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agrovet
Biopharma
Dollvet
FGBI - Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d'Algerie
Intervac (PVT) Ltd.
JOVAC
Tiankang Biopharmacuetical
Vetal Company
Veterinary Research Institute
Global Sheep and Goat Pox Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sheep and Goat Pox Vaccines market, Segment by Type:
Attenuated Live Vaccines
Killed Vaccines
Global Sheep and Goat Pox Vaccines market, by Application
Sheep
Goat
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sheep and Goat Pox Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sheep and Goat Pox Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Sheep and Goat Pox Vaccines Market Overview
1.1 Sheep and Goat Pox Vaccines Product Overview
1.2 Sheep and Goat Pox Vaccines Market Segment by Type
1.2.1 Attenuated Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Sheep and Goat Pox Vaccines Market Size by Type
1.3.1 Global Sheep and Goat Pox Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Sheep and Goat Pox Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sheep and Goat Pox Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sheep and Goat Pox Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sheep and Goat Pox Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sheep and Goat Pox Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sheep and Goat Pox Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sheep and Goat Pox Vaccines Sales Breakdown by Type (2018-2023)
2 Global Sheep and Goat Pox Vaccines Market Competition by Company
2.1 Global Top Players by Sheep and Goat Pox Vaccines Sales (2018-2023)
2.2 Global Top Players by Sheep and Goat Pox Vaccines Revenue (2018-2023)
2.3 Global Top Players by Sheep and Goat Pox Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Sheep and Goat Pox Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sheep and Goat Pox Vaccines Market Competitive Situation and Trends
2.5.1 Sheep and Goat Pox Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sheep and Goat Pox Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sheep and Goat Pox Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Sheep and Goat Pox Vaccines Market
2.8 Key Manufacturers Sheep and Goat Pox Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sheep and Goat Pox Vaccines Status and Outlook by Region
3.1 Global Sheep and Goat Pox Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sheep and Goat Pox Vaccines Historic Market Size by Region
3.2.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Sheep and Goat Pox Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Sheep and Goat Pox Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sheep and Goat Pox Vaccines Forecasted Market Size by Region
3.3.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Sheep and Goat Pox Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Sheep and Goat Pox Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sheep and Goat Pox Vaccines by Application
4.1 Sheep and Goat Pox Vaccines Market Segment by Application
4.1.1 Sheep
4.1.2 Goat
4.2 Global Sheep and Goat Pox Vaccines Market Size by Application
4.2.1 Global Sheep and Goat Pox Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Sheep and Goat Pox Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sheep and Goat Pox Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sheep and Goat Pox Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sheep and Goat Pox Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sheep and Goat Pox Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sheep and Goat Pox Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sheep and Goat Pox Vaccines Sales Breakdown by Application (2018-2023)
5 North America Sheep and Goat Pox Vaccines by Country
5.1 North America Sheep and Goat Pox Vaccines Historic Market Size by Country
5.1.1 North America Sheep and Goat Pox Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sheep and Goat Pox Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Sheep and Goat Pox Vaccines Sales in Value by Country (2018-2023)
5.2 North America Sheep and Goat Pox Vaccines Forecasted Market Size by Country
5.2.1 North America Sheep and Goat Pox Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Sheep and Goat Pox Vaccines Sales in Value by Country (2024-2029)
6 Europe Sheep and Goat Pox Vaccines by Country
6.1 Europe Sheep and Goat Pox Vaccines Historic Market Size by Country
6.1.1 Europe Sheep and Goat Pox Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sheep and Goat Pox Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Sheep and Goat Pox Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Sheep and Goat Pox Vaccines Forecasted Market Size by Country
6.2.1 Europe Sheep and Goat Pox Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Sheep and Goat Pox Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Sheep and Goat Pox Vaccines by Region
7.1 Asia-Pacific Sheep and Goat Pox Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Sheep and Goat Pox Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sheep and Goat Pox Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sheep and Goat Pox Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sheep and Goat Pox Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Sheep and Goat Pox Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sheep and Goat Pox Vaccines Sales in Value by Region (2024-2029)
8 Latin America Sheep and Goat Pox Vaccines by Country
8.1 Latin America Sheep and Goat Pox Vaccines Historic Market Size by Country
8.1.1 Latin America Sheep and Goat Pox Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sheep and Goat Pox Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sheep and Goat Pox Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Sheep and Goat Pox Vaccines Forecasted Market Size by Country
8.2.1 Latin America Sheep and Goat Pox Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sheep and Goat Pox Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Sheep and Goat Pox Vaccines by Country
9.1 Middle East and Africa Sheep and Goat Pox Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Sheep and Goat Pox Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sheep and Goat Pox Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sheep and Goat Pox Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sheep and Goat Pox Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Sheep and Goat Pox Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sheep and Goat Pox Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Agrovet
10.1.1 Agrovet Company Information
10.1.2 Agrovet Introduction and Business Overview
10.1.3 Agrovet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Agrovet Sheep and Goat Pox Vaccines Products Offered
10.1.5 Agrovet Recent Development
10.2 Biopharma
10.2.1 Biopharma Company Information
10.2.2 Biopharma Introduction and Business Overview
10.2.3 Biopharma Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Biopharma Sheep and Goat Pox Vaccines Products Offered
10.2.5 Biopharma Recent Development
10.3 Dollvet
10.3.1 Dollvet Company Information
10.3.2 Dollvet Introduction and Business Overview
10.3.3 Dollvet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Dollvet Sheep and Goat Pox Vaccines Products Offered
10.3.5 Dollvet Recent Development
10.4 FGBI - Federal Centre for Animal Health
10.4.1 FGBI - Federal Centre for Animal Health Company Information
10.4.2 FGBI - Federal Centre for Animal Health Introduction and Business Overview
10.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Products Offered
10.4.5 FGBI - Federal Centre for Animal Health Recent Development
10.5 Hester Biosciences Limited
10.5.1 Hester Biosciences Limited Company Information
10.5.2 Hester Biosciences Limited Introduction and Business Overview
10.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Products Offered
10.5.5 Hester Biosciences Limited Recent Development
10.6 Indian Immunologicals Limited
10.6.1 Indian Immunologicals Limited Company Information
10.6.2 Indian Immunologicals Limited Introduction and Business Overview
10.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Products Offered
10.6.5 Indian Immunologicals Limited Recent Development
10.7 Institut Pasteur d'Algerie
10.7.1 Institut Pasteur d'Algerie Company Information
10.7.2 Institut Pasteur d'Algerie Introduction and Business Overview
10.7.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Products Offered
10.7.5 Institut Pasteur d'Algerie Recent Development
10.8 Intervac (PVT) Ltd.
10.8.1 Intervac (PVT) Ltd. Company Information
10.8.2 Intervac (PVT) Ltd. Introduction and Business Overview
10.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Products Offered
10.8.5 Intervac (PVT) Ltd. Recent Development
10.9 JOVAC
10.9.1 JOVAC Company Information
10.9.2 JOVAC Introduction and Business Overview
10.9.3 JOVAC Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 JOVAC Sheep and Goat Pox Vaccines Products Offered
10.9.5 JOVAC Recent Development
10.10 Tiankang Biopharmacuetical
10.10.1 Tiankang Biopharmacuetical Company Information
10.10.2 Tiankang Biopharmacuetical Introduction and Business Overview
10.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Products Offered
10.10.5 Tiankang Biopharmacuetical Recent Development
10.11 Vetal Company
10.11.1 Vetal Company Company Information
10.11.2 Vetal Company Introduction and Business Overview
10.11.3 Vetal Company Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Vetal Company Sheep and Goat Pox Vaccines Products Offered
10.11.5 Vetal Company Recent Development
10.12 Veterinary Research Institute
10.12.1 Veterinary Research Institute Company Information
10.12.2 Veterinary Research Institute Introduction and Business Overview
10.12.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Products Offered
10.12.5 Veterinary Research Institute Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sheep and Goat Pox Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sheep and Goat Pox Vaccines Industrial Chain Analysis
11.4 Sheep and Goat Pox Vaccines Market Dynamics
11.4.1 Sheep and Goat Pox Vaccines Industry Trends
11.4.2 Sheep and Goat Pox Vaccines Market Drivers
11.4.3 Sheep and Goat Pox Vaccines Market Challenges
11.4.4 Sheep and Goat Pox Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sheep and Goat Pox Vaccines Distributors
12.3 Sheep and Goat Pox Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock